中文 | English
Return
Total: 2 , 1/1
Show Home Prev Next End page: GO
Author:(Hanren DAI)

1.Phase I study of chimeric antigen receptor modified T cells in treating HER2-positive advanced biliary tract cancers and pancreatic cancers.

Kaichao FENG ; Yang LIU ; Yelei GUO ; Jingdan QIU ; Zhiqiang WU ; Hanren DAI ; Qingming YANG ; Yao WANG ; Weidong HAN

Protein & Cell 2018;9(10):838-847

2.Effective and persistent antitumor activity of HER2-directed CAR-T cells against gastric cancer cells in vitro and xenotransplanted tumors in vivo.

Yanjing SONG ; Chuan TONG ; Yao WANG ; Yunhe GAO ; Hanren DAI ; Yelei GUO ; Xudong ZHAO ; Yi WANG ; Zizheng WANG ; Weidong HAN ; Lin CHEN

Protein & Cell 2018;9(10):867-878

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 2 , 1/1 Show Home Prev Next End page: GO